|
ASI TECHNOLOGY CORPORATION RECEIVES U.S. GOVERNMENT GRANT TO STUDY PLASMA FOR BIOLOGICAL DECONTAMINATION Eastern Virginia Medical School Researchers to Participate in Study (LAS VEGAS, Nevada, August 15, 2002)--ASI Technology Corporation (OTCBB: ASIT) announced that it has received a $99,000 Phase I contract under the Small Business Technology Transfer (STTR) grant program of the U.S. Air Force Office of Scientific Research. ASI researchers will collaborate with researchers from Eastern Virginia Medical School (Norfolk, Virginia) in a one-year study targeted at using atmospheric pressure plasmas to sterilize biologically contaminated surfaces. ASI's plasma scientist, Professor Igor Alexeff of the University of Tennessee, has patented a method for using an airborne plasma discharge to destroy microorganisms. Dr. Alexeff stated, "This study will focus on designing an apparatus for decontamination of equipment and facilities that have been exposed to deadly biological agents. This method could have broad applications in sterilization techniques throughout the civilian and military communities." Professor Alexeff is one of the founders of The Nuclear and Plasma Sciences Society of The Institute of Electrical and Electronics Engineers, and is immediate Past President of the Society. Dr. Ted Anderson,
Principal Investigator for ASI, on the project added "This project
will further our pioneering work in plasma technologies. We are on the
leading edge of plasma research employing plasmas in reconfigurable antennas
and antenna arrays, smart antennas, communications, radar, shielding/filtering,
waveguides, and in jet engine noise reduction." The STTR program is designed for cooperative research conducted jointly by small business concerns and research institutions. ASI is pleased to be working with researchers from Eastern Virginia Medical School on this project. Stephen J. Beebe, Ph.D., Associate Professor of Pediatrics at EVMS, has performed important work in Electro-Medicine applying electric fields on biological cells. He has received previous support from the Air Force Office of Scientific Research, the National Institutes of Health and the American Cancer Society among others. Dr. Beebe will be the lead researcher on the EVMS team and added "We are very pleased to work with Dr. Alexeff and Dr. Anderson to further the study of plasma discharges for biological decontamination." Headquartered in Henderson, Nevada, ASI Technology is focused on plasma technologies. Plasma is the fourth state of matter and most of the Universe is in the plasma state. ASI Technology is dedicated to the rapidly growing field of plasma-based technology. ASI Technology owns a number of patented plasma technologies including plasma antenna technology, plasma waveguides, and plasma sound reduction technology for jet engines. About ASI Technology Corporation - ASI specializes in the development of advanced patented plasma technologies in support of DOD and commercial organizations. ASI staff has extensive experience in the disciplines of science, physics, engineering and mathematics with a focus on advanced plasma physics. ASI has innovated and patented new applications of plasma in the areas of antennas, communication links, electronic shielding and noise reduction. The Company has worked on plasma projects with General Dynamics, University of Tennessee, the U.S. Missile Defense Agency, the U.S. Navy and Malibu Research, Inc. About Eastern Virginia Medical School - Eastern Virginia Medical School (EVMS) is a community based medical school that is affiliated with hospitals and health care organizations throughout eastern Virginia and serves as the foundation of the region's health care system. Two major hospitals, The Children's Hospital of the King's Daughters (CHKD) and Sentara Norfolk General Hospital (SNGH), are on the EVMS campus. EVMS is the largest biomedical research institution in Southeastern Virginia as well as the area's largest medical center complex. The institution offers several educational programs including degrees in Medicine (M.D), Graduate Art Therapy, Doctorate in Biomedical Sciences (PhD), Master's in Biomedical Sciences (Medical Master's or Research Track), Master of Physician Assistant (MPA), Master of Public Health (MPH), Surgical Assistant (SA), and Virginia Consortium in Clinical Psychology (Psy.D.). Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This document contains forward-looking statements relating to future performance, technology and product development that may affect future results and the future viability of the company. Actual results could be affected or differ materially from those projected in the forward-looking statements as a result of risks and uncertainties, including development results, technological shifts, potential technical difficulties that could delay new technology, competition, general economic factors, the uncertainty of market acceptance of new technology, and other factors identified and discussed in the Company's most recent filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from the Company's current expectations. FOR FURTHER INFORMATION CONTACT: Jerry E.
Polis Jane Gardner
|